Establishment Labs to Announce First Quarter 2024 Financial Results on May 8

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its

BusinesswireApr 24 20:30

Establishment Labs Announces Participation in The Aesthetic Meeting 2024

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its

BusinesswireApr 17 20:30

Establishment Labs Is Maintained at Buy by Citigroup

Establishment Labs Is Maintained at Buy by Citigroup

Dow JonesApr 3 23:56

Citigroup Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $60

Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs with a Buy and raises the price target from $49 to $60.

Analyst UpgradesApr 3 23:46

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)

TipRanksApr 3 17:32

Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility

Establishment Labs (ESTA) said Tuesday that the US Food and Drug Administration scheduled a PMA preapproval inspection of the company's manufacturing facility for Motiva Implants. The inspection is se

MT NewswiresApr 2 23:47